Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Turner BioSystems was a developer and manufacturer of high-performance optical detection systems for life science research. Based in Sunnyvale, California, the company specialized in luminometers, fluorometers, and multimode microplate readers designed for sensitive biological assays. Their product portfolio, including the Modulus and Veritas systems, supported a wide range of applications such as gene reporter assays, cell viability testing, and nucleic acid quantification. In March 2009, Turner BioSystems was acquired by Promega Corporation, a global leader in life science reagents and integrated systems. This acquisition allowed Promega to combine its proprietary reagent chemistries with Turner's detection hardware to provide complete workflow solutions for researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Turner BioSystems.